Challenging Case Studies are presented by trainees or technologists. They will discuss the case's clinical history, molecular analysis, interesting features, and the proposed diagnosis. Other molecular testing methods, if applicable, will be included in the presentation, including biopsies, gross/microscopic pathology, immunohistochemistry/flow cytometry, and cytogenetic findings.
A Surprising Finding in Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma
Mark Evans, MD, University of California, Irvine, Orange, CA, USA
Clonal Selection Following FLT3 Tyrosine Kinase Inhibitor Treatment for Acute Myeloid Leukemia
Adam Fisch, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA
Identification of a Cryptic ABL1 Rearrangement in a Refractory Acute Myeloid Leukemia Patient with Diploid Karyotype by Conventional Cytogenetics
Arash Ronaghy, MD, PhD, MD Anderson Cancer Center, Houston, TX, USA
Muddy Waters: A Report of Granulocytes Infusion Confounding Next-Generation Sequencing Interpretation
Tareq Qdaisat, MD, University of Nebraska Medical Center, Omaha, NE, USA
Objectives:
- Describe the context of a challenging clinical case.
- Discuss the molecular pathology techniques used in the diagnosis of the case.
- Propose a final diagnosis based upon findings and diagnostic evidence.
Duration: 0.75 hr
Recording Date: November 7, 2019
CME/CMLE credit: 0.75 hr
Last day to purchase course and CE claim credit: December 24, 2022
